Related Experiment Video

Updated: Jul 12, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

Biomarkers of the Complement System in Cancer

Elif Kubat Oktem1

  • 1Istanbul Medeniyet University Faculty of Engineering and Natural Sciences, Department of Molecular Biology and Genetics, Istanbul, Türkiye.

Medeniyet Medical Journal
|March 28, 2025
PubMed
Abstract

Insights

This study identifies key complement system proteins as common cancer biomarkers, including component 7 (C7) and complement factor-D (CFD). These findings offer potential for developing targeted cancer therapies and precision medicine approaches.

Area of Science:

  • Oncology
  • Immunology
  • Genomics

Background:

  • Cancer involves unregulated cell division, with targeted therapies emerging from oncogene and tumor suppressor gene research.
  • The complement system, a part of innate immunity, plays a role in cancer development and progression.
  • Understanding shared complement biomarkers across diverse cancer types is crucial for advancing personalized medicine.

Purpose of the Study:

  • To investigate biomarkers that link the complement system to carcinogenesis.
  • To identify common gene expression variations and complement biomarkers in different cancer types.

Main Methods:

  • Utilized clinical and transcriptome data from The Cancer Genome Atlas (TCGA).
  • Employed bioinformatics and machine learning techniques to analyze differentially expressed genes within the complement system.
  • Identified potential complement pathway-related biomarkers for carcinogenesis.

Main Results:

  • Elucidated five key proteins: component 7 (C7), complement factor-D (CFD), interleukin-11 (IL11), apolipoprotein C1 (APOC1), and integrin binding sialic acid protein (IBSP).
  • These proteins were identified as common biomarkers associated with the complement system across various cancers.
  • Highlighted the diagnostic and prognostic potential of these identified biomarkers.

Conclusions:

  • The identified complement system proteins serve as significant biomarkers in cancer.
  • These biomarkers hold promise for advancing targeted cancer treatments within precision medicine.
  • Further research into these biomarkers can lead to more precise and personalized therapeutic strategies.
Keywords:
Neoplasmscomplement system proteinssystems biologytranscriptome

More Related Videos

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening

Published on: October 26, 2017

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion06:54

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion

Published on: June 15, 2019

Related Concept Videos

Selectins01:25

Selectins

Cell adhesion is  an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain, which...
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...